Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shares were down 5.2% during mid-day trading on Tuesday . The company traded as low as $39.86 and last traded at $39.86. 1,102 shares traded hands during trading, a decline of 18% from the average session volume of 1,352 shares. The stock had previously closed at $42.05.
Hikma Pharmaceuticals Stock Down 5.2%
The firm’s fifty day moving average price is $40.03 and its 200 day moving average price is $39.20.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
